Oracle Corporation et al v. Druglogic, Inc.

Filing 97

STIPULATION AND ORDER GRANTING ORACLE LEAVE TO AMEND ITS ANSWER AND DEFENSES. Signed by Judge Joseph C. Spero on 12/12/11. (klhS, COURT STAFF) (Filed on 12/12/2011)

Download PDF
Case3:11-cv-00910-JCS Document96 1 2 3 4 5 6 7 Filed12/09/11 Page1 of 2 KAREN JOHNSON-MCKEWAN (State Bar No. 121570) kjohnson-mckewan@orrick.com I. NEEL CHATTERJEE (State Bar No. 173985) nchatterjee@orrick.com MICHAEL C. SPILLNER (State Bar No. 205785) mspillner@orrick.com ORRICK, HERRINGTON & SUTCLIFFE LLP 1000 Marsh Road Menlo Park, CA 94025 Telephone: (650) 614-7400 Fax: (650) 614-7401 Attorneys for Plaintiffs and Counterclaim Respondents Oracle Corp., Oracle Int’l Corp., and Oracle America, Inc. 8 13 PETER J. DAVIS (Admitted pro hac vice) pdavis@wtplaw.com STEVEN E. TILLER (Admitted pro hac vice) stiller@wtplaw.com WHITEFORD, TAYLOR & PRESTON Seven Saint Paul Street Baltimore, MD 21202 Phone: 410-347-8738 Fax: 410-223-4304 14 Attorneys for Defendant and Counterclaimant DrugLogic, Inc. 9 10 11 12 15 16 UNITED STATES DISTRICT COURT 17 NORTHERN DISTRICT OF CALIFORNIA 18 19 20 21 22 ORACLE CORPORATION and ORACLE INTERNATIONAL CORPORATION, Plaintiffs, v. DRUGLOGIC, INC., Defendant. 23 24 25 26 27 Counterclaimant, v. ORACLE CORPORATION, ORACLE INTERNATIONAL CORPORATION, and ORACLE AMERICA, INC., Counterclaim Defendants. OHSWEST:261415888.1 STIPULATION AND [PROPOSED] ORDER GRANTING ORACLE LEAVE TO AMEND ITS ANSWER AND DEFENSES The Honorable Joseph C. Spero DRUGLOGIC, INC., 28 Case No. 11-cv-00910 JCS Case3:11-cv-00910-JCS Document96 Filed12/09/11 Page2 of 2 1 The parties jointly request that Plaintiffs and Counterclaim Defendants Oracle 2 Corporation, Oracle International Corporation, and Oracle America Inc. (“Oracle”) be granted 3 leave to amend their “Answer and Defenses to DrugLogic, Inc.’s Second Amended 4 Counterclaims” (“Answer and Defenses”). Oracle filed its Answer and Defenses on November 5 30, 2011. The parties believe that an amendment will promote judicial economy by potentially 6 avoiding motion practice relating to the sufficiency of Oracle’s pleading. The amendment will 7 not affect the Court’s schedule. Accordingly, the parties, by and through their counsel of record, 8 hereby stipulate and agree that: 9 1. Oracle may amend its Answer and Defenses by December 19, 2011. 10 11 STIPULATED AND AGREED: 12 Dated: December 9, 2011 13 MICHAEL C. SPILLNER ORRICK, HERRINGTON & SUTCLIFFE LLP 17 18 19 Concurrence in the filing of this document has been obtained pursuant to General Order 45. PURSUANT TO STIPULATION, IT IS SO ORDERED. 22 UNIT ED 23 NO Dated: 12/12/11 ISTRIC ES D TC AT T JOSEPH C. SPERO United States Magistrate Judge RT ER 25 26 27 28 OHSWEST:261415888.1 Spero A H 24 seph C. Judge Jo LI 21 RT U O 20 /s/ Steven E. Tiller /s/ Steven E. Tiller Attorneys for DrugLogic, Inc. R NIA 16 /s/ Michael C. Spillner /s/ Michael C. Spillner Attorneys for Oracle Corp., Oracle Int’l Corp., and Oracle America, Inc. FO 15 S 14 STEVEN E. TILLER WHITEFORD, TAYLOR & PRESTON N F D IS T IC T O R C

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?